Elmore R H, Wadkins R M, Graves D E
Department of Chemistry, University of Mississippi 38677.
Nucleic Acids Res. 1988 Oct 25;16(20):9707-19. doi: 10.1093/nar/16.20.9707.
The equilibrium binding of the antitumor agent m-AMSA (4'-(9-acridinylamino) methane-sulfon-m-ansidide) has been examined by optical methods. These studies which have focused on the low bound drug concentrations (r values less than 0.02, base pairs) reveal m-AMSA to bind calf thymus DNA in a highly cooperative manner as indicated by the initial positive slope of the Scatchard plot. In contrast, the studies on the parent 9-aminoacridine under identical conditions demonstrate that this compound binds DNA in a noncooperative (neighbor exclusion) manner. The positive cooperative binding phenomenon of m-AMSA is probed as a function of ionic concentration and shown to exist over the range of salt concentrations examined (0.01 to 0.1 M); however, the magnitude of the cooperative binding is altered. This observation of cooperativity is consistent with earlier studies on biologically active compounds and may be related to such binding parameters as binding sequence selectivity and/or structural perturbations to the DNA structure.
已通过光学方法研究了抗肿瘤药物间-氨茴酰吖啶(4'-(9-吖啶基氨基)甲磺酰间-茴香胺)的平衡结合情况。这些聚焦于低结合药物浓度(r值小于0.02,碱基对)的研究表明,如Scatchard图的初始正斜率所示,间-氨茴酰吖啶以高度协同的方式结合小牛胸腺DNA。相比之下,在相同条件下对母体9-氨基吖啶的研究表明,该化合物以非协同(邻位排斥)方式结合DNA。研究了间-氨茴酰吖啶的正协同结合现象与离子浓度的关系,结果表明在所研究的盐浓度范围(0.01至0.1 M)内该现象均存在;然而,协同结合的程度发生了改变。这种协同性的观察结果与早期对生物活性化合物的研究一致,并且可能与诸如结合序列选择性和/或对DNA结构的结构扰动等结合参数有关。